Please go to Enter Survey and review Ron Allen's talk entitled "New Method and Catheter to Treat Patients Experiencing Kidney Failure." Pre-registration is now open for the August 8th B2DG evening meeting with Anupam Agarwal on "Drug Safety and Pharmacovigilance, the Past, Present and Future." Please go to to Register and pay thru our Paypal link.

The Bio2Device Group (B2DG) is a premier organization for all San Francisco Bay Area professionals in pharmaceutical, biotech, medical device, diagnostics and other life science industry sectors. Weekly programs are designed to keep members up-to-date with industry news, help them explore other industry sectors, and provide networking opportunities with other life science professionals from all industry sectors and corporate functions. The B2DG also hosts a moderated LinkedIn Group to facilitate communication between members.

Our Next Event

Ronald C. Allen, PhD - CEO & President - Chrysalis Medical
07/25/2017 - 8:30am
Sunnyvale City Council Chambers- 456 West Olive Ave., Sunnyvale

Ron will present and discuss a newly developed method to treat Chronic Kidney Failure developed by Chrysalis Medical.

Chrysalis Medical, Inc. is a developer, manufacturer, and marketer of breakthrough, disruptive medical technologies. In concert with university research facilities, physicians, entrepreneurs, and engineers, Chrysalis reviews and evaluates promising medical technologies...

Syndicate content